Literature DB >> 21559791

Information overload in oncology practice and its potential negative impact on the delivery of optimal patient care.

Maurie Markman1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21559791     DOI: 10.1007/s11912-011-0179-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  14 in total

1.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

Review 2.  Germline genetic variation, cancer outcome, and pharmacogenetics.

Authors:  Linda Coate; Sinead Cuffe; Anne Horgan; Rayjean J Hung; David Christiani; Geoffrey Liu
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  Trastuzumab in the treatment of breast cancer.

Authors:  Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

4.  Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Authors:  Wendy De Roock; Derek J Jonker; Federica Di Nicolantonio; Andrea Sartore-Bianchi; Dongsheng Tu; Salvatore Siena; Simona Lamba; Sabrina Arena; Milo Frattini; Hubert Piessevaux; Eric Van Cutsem; Chris J O'Callaghan; Shirin Khambata-Ford; John R Zalcberg; John Simes; Christos S Karapetis; Alberto Bardelli; Sabine Tejpar
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

5.  Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

Authors:  Daniela Cardinale; Alessandro Colombo; Rosalba Torrisi; Maria T Sandri; Maurizio Civelli; Michela Salvatici; Giuseppina Lamantia; Nicola Colombo; Sarah Cortinovis; Maria A Dessanai; Franco Nolè; Fabrizio Veglia; Carlo M Cipolla
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

6.  Inhibition of mutated, activated BRAF in metastatic melanoma.

Authors:  Keith T Flaherty; Igor Puzanov; Kevin B Kim; Antoni Ribas; Grant A McArthur; Jeffrey A Sosman; Peter J O'Dwyer; Richard J Lee; Joseph F Grippo; Keith Nolop; Paul B Chapman
Journal:  N Engl J Med       Date:  2010-08-26       Impact factor: 91.245

7.  Dose-dependent association between UGT1A1*28 genotype and irinotecan-induced neutropenia: low doses also increase risk.

Authors:  Zhe-Yi Hu; Qi Yu; Qi Pei; Cheng Guo
Journal:  Clin Cancer Res       Date:  2010-06-18       Impact factor: 12.531

8.  Personalized medicine and inhibition of EGFR signaling in lung cancer.

Authors:  Adi F Gazdar
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

9.  Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.

Authors:  J Alexander; N Dainiak; H J Berger; L Goldman; D Johnstone; L Reduto; T Duffy; P Schwartz; A Gottschalk; B L Zaret
Journal:  N Engl J Med       Date:  1979-02-08       Impact factor: 91.245

Review 10.  American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

Authors:  Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

View more
  2 in total

1.  Convergent evolution of health information management and health informatics: a perspective on the future of information professionals in health care.

Authors:  C J Gibson; B E Dixon; K Abrams
Journal:  Appl Clin Inform       Date:  2015-03-18       Impact factor: 2.342

2.  Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.

Authors:  Karen Hurley; Lisa R Rubin; Allison Werner-Lin; Michal Sagi; Yelena Kemel; Rikki Stern; Aliza Phillips; Ina Cholst; Noah Kauff; Kenneth Offit
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.